Q4 Investor Presentation Feb 2026 Disclosures Forward-Looking Statements This presentation may contain "forward-looking statements," which include information concerning Celanese Corporation's (the "Company") plans objectives, goals, strategies, future revenues, cash flow, financial performance, synergies, capital expenditures, deleveraging efforts, planned cost reductions, dividend policy, financing needs and other information that is not historical information. All forward-looking statements are based upo ...

Core Insights - Celanese Corporation reported fourth-quarter results that missed analyst expectations for both earnings and revenue, yet shares rose over 4% in after-hours trading [1] Financial Performance - Adjusted earnings per share for the fourth quarter were $0.67, below the consensus estimate of $0.91 [1] - Revenue for the fourth quarter totaled $2.2 billion, slightly under the forecast of $2.25 billion and down 6.5% from $2.36 billion in the same quarter last year [1][2] - The company recorded an operating profit of $93 million and adjusted EBIT of $251 million for the fourth quarter [2] Yearly Overview - For the full year 2025, Celanese generated adjusted earnings per share of $3.98 on net sales of $9.5 billion, representing a 7% year-over-year decline [3] - Operating cash flow totaled $1.1 billion, while free cash flow reached $773 million [3] Future Outlook - The company expects limited change in the demand environment during the first quarter, with seasonal volume improvements offset by the timing of dividend payments from its acetate tow joint venture in China [4] - Celanese forecasts first-quarter adjusted EPS of $0.70 to $0.85 and targets free cash flow between $650 million and $750 million for 2026 [4]

Management attributed the 2025 earnings decline primarily to volume and price headwinds in the Acetyl Chain, particularly within the acetate tow business and margin compression in China. Engineered Materials performance was driven by a balance of volume and price declines, partially offset by cost reduction initiatives and favorable NAFTA deals. The company is shifting its internal mantra to include a growth focus, specifically targeting high-growth sectors like AI-driven electronics and data centers ...

分组1 - Celanese reported quarterly earnings of $0.67 per share, missing the Zacks Consensus Estimate of $0.89 per share, and down from $1.45 per share a year ago, representing an earnings surprise of -24.62% [1] - The company posted revenues of $2.2 billion for the quarter, missing the Zacks Consensus Estimate by 1.16%, and down from $2.37 billion year-over-year [2] - Celanese shares have increased by approximately 39.2% since the beginning of the year, while the S&P 500 has declined by 0.1% [3] 分组2 - The current consensus EPS estimate for the upcoming quarter is $0.89 on revenues of $2.4 billion, and for the current fiscal year, it is $5.45 on revenues of $9.57 billion [7] - The Zacks Industry Rank for Chemical - Specialty is currently in the bottom 25% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

Exhibit 99.2 Non-U.S. GAAP Financial Measures and Supplemental Information February 17, 2026 In this document, the terms the "Company," "we" and "our" refer to Celanese Corporation and its subsidiaries on a consolidated basis. Purpose The purpose of this document is to provide information of interest to investors, analysts and other parties including supplemental financial information and reconciliations and other information concerning our use of non-U.S. GAAP financial measures. This document is updated q ...

Core Viewpoint - Celanese Corporation is expected to report a decline in earnings and revenue for its fourth quarter compared to the previous year [1][2]. Financial Performance - Analysts predict Celanese will report quarterly earnings of 91 cents per share, a decrease from $1.45 per share in the same quarter last year [1]. - The consensus estimate for quarterly revenue is $2.25 billion, down from $2.37 billion a year earlier [1]. Dividend Information - On February 11, Celanese declared a quarterly dividend of 3 cents per share [1]. Stock Performance - Celanese shares increased by 0.1% to close at $58.85 on the previous Friday [2].

Price Increase Summary - The company has announced a price increase for several chemical products across different regions, including the USA, Canada, Mexico, South America, and EMEA [1] Product Pricing Details - Acetic Acid prices will increase by $50 in the USA and Canada, $50 in Mexico and South America, and €50 in EMEA [1] - Vinyl Acetate Monomer prices will rise by $100 in the USA and Canada, $100 in Mexico and South America, and €100 in EMEA [1] - Acetic Anhydride prices will see an increase of $60 in all regions: USA, Canada, Mexico, South America, and EMEA [1] - Esters will also have a price increase of $50 across the USA, Canada, Mexico, South America, and €50 in EMEA [1]

Market Overview - The S&P 500 and Nasdaq Composite declined by 0.1% and 1.9% respectively, while the Dow Jones Industrial Average increased by 2.5% last week, indicating a mixed performance across major indexes [1] - The divergence in market performance was attributed to a rotation in investor preferences rather than overall market weakness, with rising Treasury yields making high-valuation growth stocks less appealing [1] Sector Performance - Optimism regarding economic resilience led to increased buying in cyclically sensitive and defensive sectors, with industrials benefiting from infrastructure and manufacturing strength, financials gaining from higher yields, and energy rising with firmer oil prices [2] - This shift underscores a focus on earnings stability and tangible cash flows among investors [2] Zacks Research Performance - Kennametal Inc. (KMT) shares surged by 44.8% since being upgraded to a Zacks Rank 1 (Strong Buy) on December 8, outperforming the S&P 500's 0.7% increase [3] - Inventiva S.A. (IVA) also saw a return of 42.4% since its upgrade to Zacks Rank 1 on the same date [4] - An equal-weight portfolio of Zacks Rank 1 stocks outperformed the equal-weight S&P 500 index by 7 percentage points, returning 17.81% compared to 10.85% for the index [4] Zacks Recommendations - Clearway Energy, Inc. (CWENA) and Pursuit Attractions and Hospitality, Inc. (PRSU) saw share increases of 16.7% and 5.4% respectively since their upgrades to Outperform on December 10 and December 11 [6] - The Zacks Recommendation system aims to predict stock performance over the next 6 to 12 months, based on trends in earnings estimate revisions [7] Focus List and Portfolios - Celanese Corporation (CE) gained 32.9% over the past 12 weeks since being added to the Zacks Focus List, while Intellia Therapeutics, Inc. (NTLA) returned 29% over the same period [9] - The Zacks Focus List portfolio returned 22.1% in 2025, outperforming the S&P 500 index's 17.9% gain [10] - The Earnings Certain Admiral Portfolio (ECAP) returned -1.67% for 2025, underperforming the S&P 500 index's 17.9% gain, but had a return of 16.26% in 2024 compared to the S&P 500's 24.89% [14] Dividend Portfolio Performance - Illinois Tool Works Inc. (ITW) and Fastenal Company (FAST) returned 19.6% and 16.8% respectively over the past 12 weeks, benefiting from investor interest in quality dividend stocks amid market volatility [16] - The Earnings Certain Dividend Portfolio (ECDP) returned -0.6% for 2025, underperforming the Dividend Aristocrat ETF's 6.8% gain [17] Top 10 Stocks Performance - Monolithic Power Systems (MPWR) increased by 31.4% since January 5, 2026, compared to the S&P 500 Index's 1.1% increase [20] - The Top 10 portfolio has produced a cumulative return of 2,472.7% since 2012, significantly outperforming the S&P 500 index's 561.6% return [21]

Core Insights - The report summarizes significant analyst rating adjustments that could influence market trends, highlighting both upgrades and downgrades across various companies [1]. Upgrades - B. Riley upgraded Snap (SNAP) from Neutral to Buy, maintaining a target price of $10, citing strong growth in high-end subscription revenue and the rollout of high-margin advertising formats [5]. - Seaport Research upgraded FuboTV (FUBO) from Neutral to Buy with a target price of $3, viewing current uncertainties as a quality investment opportunity following a significant stock drop post-earnings [5]. - Wolfe Research upgraded Zoom Video Communications (ZM) from Peer Perform to Outperform, setting a target price of $115, anticipating a re-acceleration in growth and strong performance in its contract center and phone business [5]. - Jefferies upgraded Celanese (CE) from Hold to Buy, raising the target price from $43 to $86, suggesting it is a good time to buy despite potential earnings volatility in the first half of 2026 [5]. - Cantor Fitzgerald upgraded DigitalOcean (DOCN) from Neutral to Overweight, increasing the target price from $47 to $68, emphasizing its focus on digital-native enterprises and a strong foundation for market expansion [5]. Downgrades - Stifel downgraded Microsoft (MSFT) from Buy to Hold, reducing the target price from $540 to $392, citing supply issues with Azure and strong competition from Google Cloud [5]. - Susquehanna downgraded Qualcomm (QCOM) from Positive to Neutral, lowering the target price from $210 to $140, recommending a wait-and-see approach due to industry challenges [5]. - Citigroup downgraded Six Flags Entertainment (FUN) from Buy to Neutral, cutting the target price from $25 to $20, citing overvaluation after a 40% increase since November [5]. - Jefferies downgraded Steven Madden (SHOO) from Hold to Underperform, lowering the target price from $37 to $30, highlighting ongoing pressures in its wholesale business [5]. - JPMorgan downgraded Corteva (CTVA) from Overweight to Neutral, raising the target price from $75 to $77, based on valuation considerations [5]. Initiations - Benchmark initiated coverage on Cava Group (CAVA) with a Buy rating and a target price of $80, recognizing its leading position in the Mediterranean dining category [5]. - H.C. Wainwright initiated coverage on Incyte (INCY) with a Buy rating and a target price of $135, noting potential catalysts that could stabilize revenue expectations post-Jakafi patent expiration [5]. - Bernstein initiated coverage on Coupang (CPNG) with an Underperform rating and a target price of $17, favoring companies with strong growth potential driven by online penetration [5]. - Benchmark initiated coverage on Andersons (ANDE) with a Buy rating and a target price of $75, highlighting the growth momentum in its ethanol business [5]. - Bank of America initiated coverage on Wave Life Sciences (WVE) with a Buy rating and a target price of $38, emphasizing the differentiated advantages of its obesity drug WVE-007 [6].

Core Insights - The article compiles significant research calls from Wall Street that are influencing market movements, highlighting upgrades for various companies based on their recent performance and future potential [1] Group 1: Company Upgrades - B. Riley upgraded Snap (SNAP) to Buy from Neutral with a price target of $10, citing early signs of progress in revenue growth from premium subscribers and higher margin advertising formats [2] - Seaport Research upgraded FuboTV (FUBO) to Buy from Neutral with a price target of $3, viewing the recent drop in shares post-merger with Disney's Hulu Live as an opportunity amidst uncertainty [2] - Wolfe Research upgraded Zoom Communications (ZM) to Outperform from Peer Perform with a price target of $115, believing the company's growth is set to reaccelerate, particularly in its contract center and phone business, along with emerging voice AI [2] - Jefferies upgraded Celanese (CE) to Buy from Hold with a price target of $86, indicating that despite expected choppy earnings in the first half of 2026, it is a good time to buy the dips [2] - Cantor Fitzgerald upgraded DigitalOcean (DOCN) to Overweight from Neutral with a price target of $68, emphasizing the company's developer-first approach to hyperscale services as well positioned for market growth [2]